| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $19.9M | -2.1% | +31.3% |
| SG&A Expense | $7.8M | +10.9% | -20.2% |
| Operating Income | -$27.7M | -1.2% | -11.1% |
| Pre-tax Income | -$24.6M | -2.3% | -12.4% |
| Income Tax | $46K | -28.1% | -25.8% |
| Net Income | -$24.6M | -2.2% | -12.3% |
| EPS (Basic) | -$0.27 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $150.7M | +3.2% | -44.2% |
| Short-term Investments | $144.9M | -14.5% | +41.2% |
| Current Assets | $300.3M | -5.8% | -20.2% |
| Total Assets | $301.7M | -5.9% | -20.2% |
| Current Liabilities | $15.4M | +19.1% | +34.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$63.1M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $52.0M | — | — |
| Financing Cash Flow | $392K | — | — |
| Free Cash Flow | -$63.1M | — | — |
| -3.8% |
| +3.6% |
| EPS (Diluted) | -$0.27 | -3.8% | +3.6% |
| $17.6M |
| +15.8% |
| +27.8% |
| Stockholders' Equity | $284.1M | -6.9% | -22.1% |